Tango GPCR 启用模型The Tango™ GPCR Enabling Model BioVector NTCC质粒载体菌种细胞基因保藏中心

Tango GPCR 启用模型The Tango™ GPCR Enabling Model

The Tango™ GPCR Enabling Model provides in an easy to use system the same reagents Invitrogen uses to make the family of Tango™ GPCR cell lines:

1. The Tango™ Arrestin2-UAS-bla U20S parental cell line that has the beta-lactamase (bla) reporter gene under the control of a UAS response element stably integrated as well as the beta-arrestin⁄TEV protease fusion protein constitutively expressed.

2.The Tango™ pDest-Gal4VP16-M vector which is used for insertion of your GPCR of interest for in the Tango™ Arrestin2-UAS-bla U2OS parental cell line.

When the Tango™ pDest-Gal4VP16-M vector containing a GPCR of interest is integrated into the parental cell line, the chimeric receptor-Gal4VP16 protein is expressed. Upon ligand binding and receptor activation the protease tagged arrestin is recruited to the receptor. The UAS response element is cleaved from the GPCR and translocates to the nucleus and drives the beta-lactamase reporter gene expression. Activation of the reporter gene provides a quantifiable measurement of the degree of interaction between the target receptor and the protease-tagged arrestin partner and is unaffected by other signaling pathways in the cell, providing an exquisitely specific readout of target receptor activation.

Tango™ GPCR Assay technology combines the benefits of the Tango™ assay platform with the highly accurate, sensitive and live-cell beta-lactamase reporter system. The Tango™ assay platform is based upon a ligand binding to a G Protein-Coupled Receptor (GPCRs) that triggers desensitization, a process mediated by the recruitment of intracellular arrestin proteins to the activated receptor. As a result, the ligand-induced activation of GPCRs may be assayed by monitoring the interaction of arrestin with the test GPCR. A major advantage of this approach is that it does not depend on the G protein signaling specificity of the target receptor.

目录：
K1820 Tango™ GPCR 启用模型
（LiveBLAzer™-FRET B⁄G 上样试剂盒、溶液 D 和其他材料应要求单独提供；请参阅方案）。
包括：
•Tango™ Arrestin2-UAS-bla U2OS 细胞
• Tango™ pDest Gal4VP16-M 载体
•Tango™ 启用模型测定方案
•检验报告

储存：
Tango™ Arrestin2-UAS-bla U2OS 细胞在干冰上运输，接收后应立即储存于液氮中。Tango™ pDest Gal4VP16-M 载体在干冰上运输，在接收后应立即储存在 -20℃ 下。

Supplier来源:BioVector NTCC Inc.
TEL电话:+86-010-53513060
Website网址: http://www.biovector.net